诺和锐特充治疗妊娠期糖尿病的临床效果观察

Clinical Observation on the Treatment of Gestational Diabetes Mellitus with Novoterol

目的探究在妊娠期糖尿病患者中采用诺和锐特充治疗的临床疗效。方法选取我院2015年2月~2017年2月收治的妊娠期糖尿病患者84例,随机分为对照组41例和治疗组43例。对照组采用诺和灵R注射治疗,治疗组采用诺和锐特充治疗,比较两组患者的临床治疗效果和治疗前后的血糖变化情况。结果治疗组治疗总有效率为95.35%,高于对照组的63.41%,差异具有统计学意义(P<0.05)。两组患者在治疗后血糖指标下降,其中治疗组的餐后2 h血糖和HOMA-IR下降程度高于对照组,HOMA-β的下降程度低于对照组,差异均具有统计学意义(P<0.05)。结论采用诺和锐特充治疗妊娠期糖尿病患者,可以提高临床治疗效果,改善血糖变化情况,值得临床推广应用。

Objective To investigate the clinical efficacy of Novoterol in the treatment of gestational diabetes mellitus.Methods 84 cases of gestational diabetes mellitus admitted in our hospital from February 2015 to February 2017 were randomly divided into control group(n=41)and treatment group(n=43).The control group was treated with Novolin R injection,and the treatment group was treated with Novoterol.The clinical effects and the changes of blood glucose before and after treatment were compared between the two groups.Results The total effective rate in the treatment group was 95.35%,which was higher than 63.41%in the control group,the difference was statistically significant(P<0.05).The blood glucose levels of the two groups decreased after treatment.The 2 hour postprandial blood glucose and HOMA-IR decreased in the treatment group was higher than that in the control group,and the decrease in HOMA-βwas lower than that in the control group,the difference was statistically significant(P<0.05).Conclusion The treatment of gestational diabetes mellitus with Novoterol can improve the clinical therapeutic effect and improve the change of blood glucose.It is worthy of clinical application.